Investment Strategy
Fidelity NorthStar® Currency Neutral Class has an open mandate to seek the best ideas wherever they may lie, based on the convictions of veteran managers.
Fidelity NorthStar® Currency Neutral Class
Performance
Annual compound performance – as at 30-Apr-2012
| Fund | Morningstar Quartile* |
Benchmark | |
| 1 month | -1.83% | — | — |
| 3 month | 4.82% | — | — |
| 6 month | 7.09% | — | — |
| 1 year | -7.27% | — | — |
| 2 year | — | — | — |
| 3 year | — | — | — |
| 5 year | — | — | — |
| 7 year | — | — | — |
| 10 year | — | — | — |
| YTD | 8.63% | — | — |
| Since Inception | -5.84% | — | — |
Calendar year performance – as at 30-Apr-2012
Growth of $10,000 since inception – as at 30-Apr-2012
Volatility meter
The volatility meter uses methodology recommended by the Fund Risk Classification Task Force of the Investment Funds Institute of Canada. The Task Force prescribes risk assessment based on historical volatility risk as measured by the standard deviation of fund performance. The Task Force also acknowledges that other types of measurable and nonmeasurable risk may exist. The Task Force reminds investors that historical performance may not be indicative of future returns and a fund’s historical volatility may not be indicative of future volatility.
View other Fidelity funds in this category:
Fund facts
NAVPU – Series B
$8.77 – as at 18-May-2012
Fund inception date
06-Apr-2011
Fund benchmark
None
Fund aggregate assets (all series)
$4.1 million
as at 30-Apr-2012
Management expense ratio - Series B
2.40% – as at 30-Nov-2011
Quarterly Top Ten Holdings
| WellPoint | |
| ENI | |
| L-3 Communications Holdings | |
| Hon Hai Precision | |
| Plantronics | |
| Seria Co. | |
| Shoppers Drug Mart | |
| Ottogi | |
| BP | |
| AstraZeneca | |
| Total number of holdings | 395 |
| Top 10 holdings aggregate | 30.4% |
Allocation to funds